By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Neurovation Labs, Inc. 



New York  New York    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

Neurovation Labs is an early stage biotech company focused on diagnosing and treating anxiety disorders and in particular Post-traumatic Stress Disorder (PTSD).

Neurovation Labs grew out of the research performed by Drs. Fanselow and Perusini that sought to understand the cause of PTSD on a physiological level. They discovered that PTSD is manifested through enduring increases in a certain protein (glutamate receptor subunit GluA1) in the amygdala, which is a region of the brain central to fear learning. This protein increase provides the first putative objective indicator of PTSD. The discovery was made using a robust model of PTSD in rodents, stress-enhanced fear learning (SEFL). With the pioneering research successfully completed, Neurovation Labs now aims to pursue development of PTSD detection methods and ultimately a cure in humans based on these discoveries.

YEAR FOUNDED:

2016

LEADERSHIP:

Founder and CEO: Jennifer N. Perusini, Ph.D.

Co-Founder and Director of Research: Michael S. Fanselow, Ph.D.

Co-Founder and COO: Cameron Bloomer

SCIENCE:

Please click here for Neurovation Labs's science.


Key Statistics


Email: contact@neurovationlabs.com.
Ownership: Private

Web Site: Neurovation Labs
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->